Results 81 to 90 of about 22,681 (186)

Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma

open access: yes, 2020
Adriamycin-based chemotherapy is commonly used for malignant soft tissue sarcoma including myxoid liposarcoma. However, in the case of unavailability or failure of the adriamycin-based regimen, trabectedin or eribulin can produce a good antitumor effect ...
Hideaki Sabe   +5 more
core   +1 more source

A single institutional experience treating adipocytic tumors: incidence, disease-related outcomes, and the clinical significance of MDM2 analysis

open access: yesOrthopedic Reviews, 2020
Adipocytic tumors exist either as a benign or malignant form. The benign variant, lipoma, is composed of normal fat tissue. Lipomas typically develop from superficial fat cells beneath the skin or mucous membranes. Liposarcoma, the malignant counterpart,
Saule Tamkus   +5 more
doaj   +1 more source

A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions

open access: yesThe Journal of Pathology: Clinical Research, Volume 12, Issue 4, July 2026.
Abstract Recurrent fusions involving FGFR1‐4 genes have been previously described in rare subsets of mostly benign chondroid and mesenchymal neoplasms involving bone and soft tissue. However, a more comprehensive analysis of sarcomas associated with FGFR fusions, including their incidence and histotypes, has not been performed.
Maximus CF Yeung   +4 more
wiley   +1 more source

About a case of paratesticular myxoid liposarcoma

open access: yes, 2018
Paratesticular liposarcomas are relatively common sarcomas in the paratesticular region, however, the myxoid variant is considered very rare. Due to the infrequency of this malignant disease, no standard treatment would be available.
Alia Zehani   +5 more
core   +1 more source

What's Your Diagnosis? Large Mediastinal Mass in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Rosane O. Cruz   +7 more
wiley   +1 more source

Rare Late Cardiac Involvement Following Resected Primary Limb Dedifferentiated Liposarcoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive subtype of soft tissue sarcoma, most commonly arising in the extremities or retroperitoneum. Cardiac involvement, whether primary or metastatic, is exceedingly rare and presents significant diagnostic and therapeutic challenges.
Azin Alizadehasl   +2 more
wiley   +1 more source

Recurrent intrathoracic dedifferentiated liposarcoma: A case report and literature review

open access: yesRespiratory Medicine Case Reports, 2019
Background: Liposarcoma (LPS) is the second most common type of soft tissue sarcoma, accounting for approximately 15–20% of all the sarcomas. Primary intrathoracic LPS, however, is quite rare.
Umair Ashraf   +5 more
doaj   +1 more source

Psychosocial Impact of Sarcoma: Challenges and Adaptation, a Meta‐Synthesis

open access: yesPsycho-Oncology, Volume 35, Issue 7, July 2026.
ABSTRACT Objectives Sarcoma is a rare and heterogeneous cancer frequently associated with significant psychosocial burden. This review aims to synthesise qualitative research to examine the psychosocial impact of sarcoma in adults, focusing on how individuals experience and make sense of disruption across diagnosis, treatment, recovery, and ...
R. Beghean   +5 more
wiley   +1 more source

Successful resection of a giant thoracic myxoid liposarcoma

open access: yes, 2018
Primary liposarcoma is an extremely rare disease. We report a case of giant thoracic myxoid liposarcoma that occupied the whole left hemithorax and was successfully resected.
Wei Chieng Pui   +3 more
core   +1 more source

Promoter Mutations in Soft Tissue Sarcomas

open access: yesThe International Journal of Biological Markers, 2016
Introduction Oncogenic hotspot mutations in the promoter region of the TERT gene have been identified in several cancer types as being associated with a worse outcome.
Nathália C. Campanella   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy